All Articles

Angie O'Leary's promotion at Commercial Vehicle Group is more than a new title. It's a strategic bet on continuity to navigate a turbulent EV transition.

New 48-week data for envudeucitinib shows 54% of patients achieved complete skin clearance, setting a new bar for oral therapies and positioning Alumis for market disruption.

Sumisho Air Lease reports a 98% profit drop in its first post-acquisition quarter, but accounting shifts mask a deeper strategic realignment for the lessor.

In a blockbuster deal with Boeing, Archer acquires key assets to build a 'physical AI' powerhouse. But with soaring losses, is it a masterstroke or a costly bet?

Tactile Medical's impressive Q2 profit growth is tempered by a product launch stumble, testing its execution as it places big bets on new markets and tech.

BODi posts a fourth straight profitable quarter, but with revenue and subscribers in freefall, is its dramatic cost-cutting a sign of health or stagnation?

Amidst declining revenue and layoffs, Rapid7's new CEO is making a bold bet on a focused, AI-driven strategy. Is this the path to renewed strength?

P3 Health Partners stuns Wall Street with a swing to profitability, but a deeper dive reveals one-time gains and a strategic pivot. Is this the new playbook?

Metagenomi Therapeutics is on track for a pivotal 2027 clinical trial, but its advanced gene editing tech faces a market wary of high-cost cures.

Facing a 50% revenue collapse and mounting losses, The Arena Group is rebranding to Paradium.AI, a high-stakes pivot to save itself with technology.

Alico's Q3 results reveal a successful pivot from citrus giant to land developer, with profits soaring and major projects advancing. How is this changing Florida?

Insight Molecular Diagnostics has key regulatory and reimbursement wins for its game-changing transplant test, but a high cash burn creates a high-stakes race to commercialization.

Shimmick Corp. posts improving financials and a record backlog, but a closer look reveals the high cost of its strategic pivot from troubled legacy projects.

Fluent's Q2 results reveal a dramatic pivot, with Commerce Media Solutions booming 90%. But can this growth and a new in-store bet outrun a stark 'going concern' warning?

Entravision's ad-tech unit soared 230% on AI, driving record profit. But with its legacy media arm in decline, can this tech pivot redefine its future?

Strong Attruby sales and new data showing superiority fuel BridgeBio’s momentum as it prepares for three FDA decisions, backed by a new $1B financing.

Wah Fu Education's stock soared after announcing a radical pivot to enterprise AI. But can custom models for agriculture and medicine save a struggling company?

A Texas tech firm just earned a major security certification for its AI. It's more than a press release—it's a blueprint for building trust in an industry on edge.

As med spa fillir launches its largest-ever expansion into new markets, its success hinges not on speed, but on a rigorous physician-led model and proprietary training.

A new study reveals small businesses are highly aware of cyber threats, yet a deeper look shows a gap between planning and true resilience. Why is a bank leading this charge?